...
首页> 外文期刊>International Journal of Experimental Diabetes Research: Experimental Diabesity Research >The Alteration in Composition and Function of Gut Microbiome in Patients with Type 2 Diabetes
【24h】

The Alteration in Composition and Function of Gut Microbiome in Patients with Type 2 Diabetes

机译:2型糖尿病患者肠道微生物组成和功能的改变

获取原文
           

摘要

Background. Diabetes mellitus (DM) has become one of the most common chronic metabolic diseases worldwide. Due to the increasing prevalence and various complications, diabetes brings about a huge financial burden to DM patients. Nowadays, more and more studies reveal the relationship between diseases and gut microbial community. We aimed to explore the alteration in composition and function of the gut microbiome in T2DM patients. Methods. A total of 137 patients with diabetes and 179 age- and gender-matched healthy controls selected from the healthy people sample center in the First Affiliated Hospital of Zhengzhou University were divided into the DM group and the Con group, respectively. We collected their venous blood for laboratory tests and stool samples for 16S rRNA sequencing. The comparison between the two groups including both composition and function of the gut microbiome is presented.Results. We found that the α-diversity of bacterial taxa in the DM group had an evident decrease compared to that in the Con group. At the phylum level, the DM group had an obvious decrease of Bacteroidetes and a marked increase of Proteobacteria, Actinobacteria, and Verrucomicrobia. At the genus level, Bacteroides and Prevotella decreased the most while Escherichia-Shigella, Lachnospiraceae_incertae_sedis, Subdoligranulum, Enterococcus, and Klebsiella had different degrees of expansion in the DM group. The ROC based on 246 optimum OTUs had very high test efficiency with an AUC of 92.25% in the training set and 90.48% in the test set. As for prediction of metabolic function, the gut microbiome of DM patients was predicted to be more active in environmental information processing and human diseases but less in metabolism. Conclusion. We observed alteration of composition and function of the gut microbiome in the DM group. These changes may provide a new treatment strategy for DM patients and new research targets.
机译:背景。糖尿病(DM)已成为全球最常见的慢性代谢疾病之一。由于患病率越来越多,并发症,糖尿病为DM患者带来了巨大的财务负担。如今,越来越多的研究揭示了疾病与肠道微生物群落之间的关系。我们旨在探讨T2DM患者肠道微生物组的组成和功能的变化。方法。共有137例糖尿病患者和179名年龄和性别匹配的健康对照,分别从郑州大学第一个附属医院的健康人员样本中心分别分别分别分为DM集团和CON组。我们为实验室试验和粪便样品收集了静脉血液,16S rRNA测序。提出了包括肠道微生物组的组成和功能的两组之间的比较。结果。我们发现,与CON组中,DM组中的细菌分类群的α-多样性具有明显的减少。在门水平上,DM组具有明显的细菌,猕猴菌和VerrucoMicrobia的显着增加。在Genus水平,Bragoides和Fvootella在大肠杆菌 - Shigella,Lachnospireae_Incertae_sedis,Subdolaranulum,肠球菌和Klebsiella在DM组中具有不同程度的扩张。基于246个最佳OTU的ROC具有非常高的测试效率,培训集中的92.25%的AUC,测试集中的90.48%。对于代谢功能的预测,DM患者的肠道微生物组预计在环境信息处理和人类疾病中更加活跃,但代谢较少。结论。我们观察到DM组中肠道微生物组的组成和功能的改变。这些变化可以为DM患者和新的研究目标提供新的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号